These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 412527)

  • 1. d-amphetamine inhibition of platelet MAO from schizophrenic patients.
    Reches A; Ebstein RP; Belmaker RH
    Biol Psychiatry; 1977 Oct; 12(5):655-9. PubMed ID: 412527
    [No Abstract]   [Full Text] [Related]  

  • 2. Low platelet MAO activity in psychiatric patients and plasma factors: no evidence for inhibitory influences on MAO in the circulating platelet population.
    Demisch L; Gebhart P; Kaczmarczyk P; von der Mühlen H; Bochnik HJ
    Biol Psychiatry; 1981 Jan; 16(1):21-33. PubMed ID: 7225472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The study of the platelet monoamine oxidase activity in chronic schizophrenic patients (author's transl)].
    Shohmori T; Kaneyuki T; Doi T; Mitani K; Kohsaka M
    Seishin Shinkeigaku Zasshi; 1977 Oct; 79(10):563-7. PubMed ID: 607254
    [No Abstract]   [Full Text] [Related]  

  • 4. Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders.
    Orsulak PJ; Schildkraut JJ; Schatzberg AF; Herzog JM
    Biol Psychiatry; 1978 Dec; 13(6):637-47. PubMed ID: 737252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The preliminary study of monoamine oxidase activity in platelets in patients with schizophrenia and affective disorder].
    Lin Y
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Dec; 25(6):325-7, 382. PubMed ID: 1304991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: lack of influence of chronic perphenazine treatment.
    Spivak B; Kosower N; Zipser Y; Shreiber-Schul N; Apter A; Tyano S; Weizman A
    Clin Neuropharmacol; 1994 Feb; 17(1):83-8. PubMed ID: 8149362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet monoamine oxidase activity and substrate preferences in schizophrenic patients.
    Meltzer HY; Stahl SM
    Res Commun Chem Pathol Pharmacol; 1974 Feb; 7(2):419-31. PubMed ID: 4594367
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet monoamine oxidase activity in patients with chronic schizophrenic illnesses untreated by neuroleptic drugs [proceedings].
    Bailey AR; Crow TJ; Johnstone EC; Owen F
    Br J Clin Pharmacol; 1975 Aug; 2(4):380P. PubMed ID: 1234010
    [No Abstract]   [Full Text] [Related]  

  • 9. Delusional misidentification and platelet monoamine oxidase.
    Barton JL; Chaparala S; Barton ES; Jackson IV; Davis LG
    Biol Psychiatry; 1980 Apr; 15(2):275-82. PubMed ID: 7417616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet monoamine oxidase response to lithium treatment in psychiatric patients.
    Huang LG; Bowden CL
    J Clin Psychopharmacol; 1984 Dec; 4(6):326-31. PubMed ID: 6512000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary tryptamine excretion in chronic schizophrenics with low platelet MAO activity.
    Sullivan JL; Coffey CE; Basuk B; Cavenar JO; Maltbie AA; Zung WW
    Biol Psychiatry; 1980 Feb; 15(1):113-20. PubMed ID: 7357050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet monoamineoxidase activity in chronic schizophrenics.
    Gerbaldo H; Rozados RV; Filinger EJ
    Medicina (B Aires); 1985; 45(1):22-4. PubMed ID: 3880103
    [No Abstract]   [Full Text] [Related]  

  • 13. [A long-term observation of the platelet monoamine oxidase activity in schizophrenic patients (author's transl)].
    Shohmori T; Kaneyuki T; Doi T; Mitani K; Kohsaka M
    Seishin Shinkeigaku Zasshi; 1978 Mar; 80(3):121-4. PubMed ID: 662975
    [No Abstract]   [Full Text] [Related]  

  • 14. [Multiple forms of thrombocyte monoamine oxidase in patients with manic-depressive psychosis and recurrent schizophrenia].
    Smirnov AV; Prilipko LL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(4):76-8. PubMed ID: 3414255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased blood platelet MAO activity in unmedicated chronic schizophrenic patients.
    Domino EF; Khanna SS
    Am J Psychiatry; 1976 Mar; 133(3):323-6. PubMed ID: 943955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet monoamine-oxidase activity in schizophrenia. Relation to genetic load of the illness and treatment with antipsychotic drugs.
    Kemali D; Maj M; Ariano MG; Salvati A
    Encephale; 1985; 11(1):31-4. PubMed ID: 2859981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preliminary study on platelet monoamine oxidase in schizophrenic patients].
    Huang MS
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1980 Apr; 13(4):193-6. PubMed ID: 7261730
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelet monoamine oxidase in an aged general population and elderly chronic schizophrenics [[proceedings].
    Bridge TP; Jeste DV; Wise CD; Potkin SG; Phelps BH; Wyatt RJ
    Psychopharmacol Bull; 1981 Jan; 17(1):103-4. PubMed ID: 7232634
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelet enzyme abnormalities in neuropsychiatric disease.
    Farmer PM
    Ann Clin Lab Sci; 1980; 10(4):263-8. PubMed ID: 6108742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eye-blink rates and platelet monoamine oxidase activity in chronic schizophrenic patients.
    Freed WJ; Kleinman JE; Karson CN; Potkin SG; Murphy DL; Wyatt RJ
    Biol Psychiatry; 1980 Apr; 15(2):329-32. PubMed ID: 7417620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.